• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CriteriaMapper:通过匹配规范化的入选标准和患者临床特征,实现从电子健康记录中自动识别临床试验队列。

CriteriaMapper: establishing the automatic identification of clinical trial cohorts from electronic health records by matching normalized eligibility criteria and patient clinical characteristics.

机构信息

GeneDx (Sema4), 333 Ludlow Street, Stamford, CT, 06902, USA.

Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY, 10029, USA.

出版信息

Sci Rep. 2024 Oct 25;14(1):25387. doi: 10.1038/s41598-024-77447-x.

DOI:10.1038/s41598-024-77447-x
PMID:39455879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11511882/
Abstract

The use of electronic health records (EHRs) holds the potential to enhance clinical trial activities. However, the identification of eligible patients within EHRs presents considerable challenges. We aimed to develop a CriteriaMapper system for phenotyping eligibility criteria, enabling the identification of patients from EHRs with clinical characteristics that match those criteria. We utilized clinical trial eligibility criteria and patient EHRs from the Mount Sinai Database. The CriteriaMapper system was developed to normalize the criteria using national standard terminologies and in-house databases, facilitating computability and queryability to bridge clinical trial criteria and EHRs. The system employed rule-based pattern recognition and manual annotation. Our system normalized 367 out of 640 unique eligibility criteria attributes, covering various medical conditions including non-small cell lung cancer, small cell lung cancer, prostate cancer, breast cancer, multiple myeloma, ulcerative colitis, Crohn's disease, non-alcoholic steatohepatitis, and sickle cell anemia. About 174 criteria were encoded with standard terminologies and 193 were normalized using the in-house reference tables. The agreement between automated and manual normalization was high (Cohen's Kappa = 0.82), and patient matching demonstrated a 0.94 F1 score. Our system has proven effective on EHRs from multiple institutions, showing broad applicability and promising improved clinical trial processes, leading to better patient selection, and enhanced clinical research outcomes.

摘要

电子健康记录(EHRs)的使用具有增强临床试验活动的潜力。然而,在 EHRs 中识别合格患者存在相当大的挑战。我们旨在开发一个 CriteriaMapper 系统来对表型入选标准进行分类,以便从 EHR 中识别出具有与这些标准相匹配的临床特征的患者。我们使用了来自西奈山数据库的临床试验入选标准和患者 EHRs。CriteriaMapper 系统旨在使用国家标准术语和内部数据库对标准进行规范化,从而实现计算能力和可查询性,以连接临床试验标准和 EHRs。该系统采用基于规则的模式识别和手动注释。我们的系统规范化了 640 个独特入选标准属性中的 367 个,涵盖了各种医疗条件,包括非小细胞肺癌、小细胞肺癌、前列腺癌、乳腺癌、多发性骨髓瘤、溃疡性结肠炎、克罗恩病、非酒精性脂肪性肝炎和镰状细胞性贫血。约有 174 个标准采用标准术语进行编码,193 个标准采用内部参考表进行规范化。自动规范化和手动规范化之间的一致性很高(Cohen's Kappa=0.82),患者匹配的 F1 评分达到 0.94。我们的系统已在多个机构的 EHRs 上得到验证,证明具有广泛的适用性和有前途的改进临床试验流程,从而更好地选择患者,并提高临床研究结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd27/11511882/fcade4ac8137/41598_2024_77447_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd27/11511882/87a36f75a9a9/41598_2024_77447_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd27/11511882/f699abbd1c79/41598_2024_77447_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd27/11511882/860dcb61604b/41598_2024_77447_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd27/11511882/838427365417/41598_2024_77447_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd27/11511882/bf9bd8d924f5/41598_2024_77447_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd27/11511882/fcade4ac8137/41598_2024_77447_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd27/11511882/87a36f75a9a9/41598_2024_77447_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd27/11511882/f699abbd1c79/41598_2024_77447_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd27/11511882/860dcb61604b/41598_2024_77447_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd27/11511882/838427365417/41598_2024_77447_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd27/11511882/bf9bd8d924f5/41598_2024_77447_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd27/11511882/fcade4ac8137/41598_2024_77447_Fig6_HTML.jpg

相似文献

1
CriteriaMapper: establishing the automatic identification of clinical trial cohorts from electronic health records by matching normalized eligibility criteria and patient clinical characteristics.CriteriaMapper:通过匹配规范化的入选标准和患者临床特征,实现从电子健康记录中自动识别临床试验队列。
Sci Rep. 2024 Oct 25;14(1):25387. doi: 10.1038/s41598-024-77447-x.
2
Optimizing Clinical Trial Eligibility Design Using Natural Language Processing Models and Real-World Data: Algorithm Development and Validation.使用自然语言处理模型和真实世界数据优化临床试验资格设计:算法开发与验证
JMIR AI. 2024 Jul 29;3:e50800. doi: 10.2196/50800.
3
Artificial Intelligence Tool for Optimizing Eligibility Screening for Clinical Trials in a Large Community Cancer Center.人工智能工具用于优化大型社区癌症中心临床试验的资格筛选。
JCO Clin Cancer Inform. 2020 Jan;4:50-59. doi: 10.1200/CCI.19.00079.
4
Conformity between protocol eligibility criteria for electronic patient identification: a comparison of clinical trials.电子患者识别的方案入选标准之间的一致性:临床试验比较
Stud Health Technol Inform. 2013;192:1167.
5
Textual inference for eligibility criteria resolution in clinical trials.用于解决临床试验中纳入标准的文本推理
J Biomed Inform. 2015 Dec;58 Suppl(Suppl):S211-S218. doi: 10.1016/j.jbi.2015.09.008. Epub 2015 Sep 14.
6
ClinicalTrials.gov as a data source for semi-automated point-of-care trial eligibility screening.ClinicalTrials.gov作为半自动即时医疗试验资格筛查的数据源。
PLoS One. 2014 Oct 21;9(10):e111055. doi: 10.1371/journal.pone.0111055. eCollection 2014.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
Increasing the efficiency of trial-patient matching: automated clinical trial eligibility pre-screening for pediatric oncology patients.提高试验患者匹配效率:针对儿科肿瘤患者的自动化临床试验资格预筛选
BMC Med Inform Decis Mak. 2015 Apr 14;15:28. doi: 10.1186/s12911-015-0149-3.
9
The value of structured data elements from electronic health records for identifying subjects for primary care clinical trials.电子健康记录中结构化数据元素在识别初级保健临床试验受试者方面的价值。
BMC Med Inform Decis Mak. 2016 Jan 11;16:1. doi: 10.1186/s12911-016-0239-x.
10
Electronic health records (EHRs) in clinical research and platform trials: Application of the innovative EHR-based methods developed by EU-PEARL.电子健康记录 (EHR) 在临床研究和平台试验中的应用:欧盟-PEARL 开发的创新型基于 EHR 方法的应用。
J Biomed Inform. 2023 Dec;148:104553. doi: 10.1016/j.jbi.2023.104553. Epub 2023 Nov 22.

本文引用的文献

1
Optimizing Clinical Trial Eligibility Design Using Natural Language Processing Models and Real-World Data: Algorithm Development and Validation.使用自然语言处理模型和真实世界数据优化临床试验资格设计:算法开发与验证
JMIR AI. 2024 Jul 29;3:e50800. doi: 10.2196/50800.
2
AutoCriteria: a generalizable clinical trial eligibility criteria extraction system powered by large language models.AutoCriteria:一个由大型语言模型驱动的可推广的临床试验纳入标准提取系统。
J Am Med Inform Assoc. 2024 Jan 18;31(2):375-385. doi: 10.1093/jamia/ocad218.
3
Transforming clinical trials: the emerging roles of large language models.
变革临床试验:大语言模型的新兴作用
Transl Clin Pharmacol. 2023 Sep;31(3):131-138. doi: 10.12793/tcp.2023.31.e16. Epub 2023 Sep 19.
4
Trends and opportunities in computable clinical phenotyping: A scoping review.可计算临床表型分析的趋势与机遇:一项范围综述
J Biomed Inform. 2023 Apr;140:104335. doi: 10.1016/j.jbi.2023.104335. Epub 2023 Mar 16.
5
A Comparison between Human and NLP-based Annotation of Clinical Trial Eligibility Criteria Text Using The OMOP Common Data Model.基于人群和基于自然语言处理的临床试验入选标准文本标注方法在 OMOP 通用数据模型下的比较。
AMIA Jt Summits Transl Sci Proc. 2021 May 17;2021:394-403. eCollection 2021.
6
A Comparison of Arden Syntax and Clinical Quality Language as Knowledge Representation Formalisms for Clinical Decision Support. Arden 语法与临床质量语言在临床决策支持中的知识表示形式比较。
Appl Clin Inform. 2021 May;12(3):495-506. doi: 10.1055/s-0041-1731001. Epub 2021 Jun 30.
7
Evaluation of an artificial intelligence clinical trial matching system in Australian lung cancer patients.澳大利亚肺癌患者人工智能临床试验匹配系统的评估
JAMIA Open. 2020 May 1;3(2):209-215. doi: 10.1093/jamiaopen/ooaa002. eCollection 2020 Jul.
8
Matching patients to clinical trials using semantically enriched document representation.使用语义丰富的文档表示法将患者与临床试验进行匹配。
J Biomed Inform. 2020 May;105:103406. doi: 10.1016/j.jbi.2020.103406. Epub 2020 Mar 10.
9
Artificial Intelligence Tool for Optimizing Eligibility Screening for Clinical Trials in a Large Community Cancer Center.人工智能工具用于优化大型社区癌症中心临床试验的资格筛选。
JCO Clin Cancer Inform. 2020 Jan;4:50-59. doi: 10.1200/CCI.19.00079.
10
Automatic trial eligibility surveillance based on unstructured clinical data.基于非结构化临床数据的自动试验资格监测。
Int J Med Inform. 2019 Sep;129:13-19. doi: 10.1016/j.ijmedinf.2019.05.018. Epub 2019 May 23.